ECONSALUT

How Health Systems Could Avert 'Triple Fail' Events That Are Harmful, Are Costly,And Result In Poor Patient Satisfaction  While re...

Publicly funded health expenditure reached 9,162m € in 2012 , although the initial budget was 8,756m €. Therefore, the size of the budget de...

The case against patents Some months ago, a WP blog hightlighted a paper by Boldrin and Levine with a straightforward title. Now you can ...

A full-fledged overhaul is needed for a risk and value-based regulation of medical devices in Europe This is exacty what medical devices ...

Default Options In Advance Directives Influence How Patients Set Goals For End-Of-Life Care The end of life is obviously a difficult perio...

The case of Tecfidera deserves a short comment. Imagine a drug for psoriasis, its active ingredient -dimethyl fumarate- modulates the immune...

I'm strongly convinced that strong patent rights spur innovation. In the case of genetics and biomarkers, the impact is even stronger. T...

To evergreen or not to evergreen, that is the question. The lawsuit in India against Novartis has ended with a verdict that imatinib faile...

Luigi Zingales has written a salient chapter on a book on preventing regulatory capture . His focus is not on the regulator, he describes th...

A Nudge Too Far? A Nudge at All? On Paying People to Be Healthy Is there a need to change " choice architecture " to adopt healt...

Early this morning on the radio this was the statement: "We live in a country in a desperate situation". The reason is that the ru...

This is the case of voluntary health insurance. Amid the current downturn, in 2012 there was an increase in the number of members (2.04%) an...

Ethical Physician Incentives — From Carrots and Sticks to Shared Purpose The strict focus on carrots and sticks in the design of physician...

From the WEF  report last year on non communicable diseases, I retrieve the size of worlwide health expenditure in 2009: World expenditu...